Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

MARKEY C MCNUTT

Allopathic & Osteopathic Physicians Medical Genetics Clinical Genetics (M.D.)

NPI
1679893010
CMS profile
1311720
Location
DALLAS, TX

General Payments · PY2018–2024

$106,084.37

  • Reported across 136 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$38,461.45

35 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

By paying entity

PY2024 · sorted by reported total

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $5,969.50 14
PY2019 $7,867.21 19
PY2020 $11,000.00 4
PY2021 $6,275.93 6
PY2022 $20,889.57 30
PY2023 $15,620.71 28
PY2024 $38,461.45 35

Payment records · PY2024 (35)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Amgen Inc. $117.67 05/02/2024 Food and Beverage Undisputed 01/23/2026 1111648874 CMS
Amgen Inc. $229.96 05/02/2024 Travel and Lodging Undisputed 01/23/2026 1111648876 CMS
Amgen Inc. $349.56 05/02/2024 Travel and Lodging Undisputed 01/23/2026 1111648878 CMS
Amgen Inc. $400.00 05/02/2024 Travel and Lodging Undisputed 01/23/2026 1111648880 CMS
Amgen Inc. $24.64 05/03/2024 Food and Beverage Undisputed 01/23/2026 1111648882 CMS
Amgen Inc. $24.64 05/03/2024 Food and Beverage Undisputed 01/23/2026 1111648884 CMS
Amgen Inc. $49.26 05/03/2024 Food and Beverage Undisputed 01/23/2026 1111648886 CMS
Amgen Inc. $64.03 05/03/2024 Food and Beverage Undisputed 01/23/2026 1111648888 CMS
Amgen Inc. $5,200.00 05/03/2024 Consulting Fee Undisputed 01/23/2026 1111648890 CMS
Amicus Therapeutics, Inc. $3,879.00 08/22/2024 Consulting Fee Undisputed 01/23/2026 1148420476 CMS
BioMarin Pharmaceutical Inc. $200.00 05/01/2024 Consulting Fee Undisputed 01/23/2026 1127059389 CMS
BioMarin Pharmaceutical Inc. $200.00 06/14/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1127062954 CMS
BioMarin Pharmaceutical Inc. $5,088.00 12/16/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1127063056 CMS
BioMarin Pharmaceutical Inc. $2,967.18 12/31/2024 Consulting Fee Undisputed 01/23/2026 1127058055 CMS
Chiesi USA, Inc. $425.00 01/11/2024 Honoraria Undisputed 01/23/2026 1151813384 CMS
Dexcom, Inc. $17.02 03/20/2024 Food and Beverage Undisputed 01/23/2026 1153320116 CMS
Eton Pharmaceuticals, Inc. $15.80 03/13/2024 Food and Beverage Undisputed 01/23/2026 1108021172 CMS
ModernaTX, Inc. $22.52 05/23/2024 Food and Beverage Undisputed 01/23/2026 1152558812 CMS
ModernaTX, Inc. $50.00 05/23/2024 Food and Beverage Undisputed 01/23/2026 1152558814 CMS
ModernaTX, Inc. $22.52 05/23/2024 Food and Beverage Undisputed 01/23/2026 1152558816 CMS
ModernaTX, Inc. $50.00 05/23/2024 Food and Beverage Undisputed 01/23/2026 1152558818 CMS
ModernaTX, Inc. $269.51 05/23/2024 Travel and Lodging Undisputed 01/23/2026 1152558820 CMS
ModernaTX, Inc. $148.95 05/23/2024 Food and Beverage Undisputed 01/23/2026 1152558822 CMS
ModernaTX, Inc. $22.52 05/23/2024 Food and Beverage Undisputed 01/23/2026 1152558824 CMS
ModernaTX, Inc. $50.00 05/23/2024 Food and Beverage Undisputed 01/23/2026 1152558826 CMS
Otsuka Pharmaceutical Development & Commercialization, Inc. $119.40 10/24/2024 Food and Beverage Undisputed 01/23/2026 1118838323 CMS
Otsuka Pharmaceutical Development & Commercialization, Inc. $1,984.27 12/01/2024 Consulting Fee Undisputed 01/23/2026 1118838325 CMS
PTC Therapeutics, Inc. $38.00 04/14/2024 Food and Beverage Undisputed 01/23/2026 1152941630 CMS
PTC Therapeutics, Inc. $14.00 04/14/2024 Food and Beverage Undisputed 01/23/2026 1152941632 CMS
PTC Therapeutics, Inc. $58.00 04/14/2024 Food and Beverage Undisputed 01/23/2026 1152941634 CMS
PTC Therapeutics, Inc. $2,500.00 05/14/2024 Consulting Fee Undisputed 01/23/2026 1152941636 CMS
Ultragenyx Pharmaceutical Inc. $7,700.00 01/22/2024 Consulting Fee Undisputed 01/23/2026 1153284877 CMS
Ultragenyx Pharmaceutical Inc. $4,900.00 01/22/2024 Consulting Fee Undisputed 01/23/2026 1153284881 CMS
Ultragenyx Pharmaceutical Inc. $560.00 01/22/2024 Consulting Fee Undisputed 01/23/2026 1153284885 CMS
Ultragenyx Pharmaceutical Inc. $700.00 01/22/2024 Consulting Fee Undisputed 01/23/2026 1153284889 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.